July 27, 2015

 IRVINE, Calif. and REHOVOT, Israel, July 27, 2015 / PRNewswire / --
Otic Pharma Ltd, a privately held pharmaceutical company focused on developing innovative therapies for ear, nose, and throat disorders, today announced the appointment of Gregory J. Flesher as chief...

January 11, 2015

We are pleased to announce that CardioGard, a Peregrine Ventures portfolio company, has received a 510(K) clearance for its Emboli protection cannula, and the device can now be imported into and marketed in the United States.

CardioGard is developing a specially designe...

January 11, 2015

Otic Pharma Announces Positive Results from a Phase 2 Trial of FoamOtic Externa, once-a-day, single antibiotic, steroid free product for Acute Otitis Externa (AOE)

Rehovot, Israel, Jan 6, 2015 – Otic Pharma, a privately held biopharmaceutical company focused on the deve...

November 18, 2014

Otic Pharma, a Peregrine Venture portfolio company, has been chosen “Startup of the Week” by Ha’aretz, a leading Israeli newspaper. 

Israeli startup inspired by soldiers cleaning their ears with bullets 
One day a doctor noticed that Israeli soldiers had a lot of ear in...

Please reload

Please reload